Jain Global LLC Erasca, Inc. Transaction History
Jain Global LLC
- $11.9 Billion
- Q2 2025
A detailed history of Jain Global LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Jain Global LLC holds 774,340 shares of ERAS stock, worth $1.97 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
774,340
Previous 31,246
2378.21%
Holding current value
$1.97 Million
Previous $42,000
2240.48%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ERAS
# of Institutions
158Shares Held
212MCall Options Held
277KPut Options Held
16.3K-
Frazier Life Sciences Management, L.P. Menlo Park, CA22.7MShares$57.7 Million2.1% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD20.2MShares$51.4 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY17.9MShares$45.4 Million4.49% of portfolio
-
Logos Global Management LP San Francisco, CA15MShares$38.1 Million2.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.5MShares$36.8 Million0.95% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $310M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...